SAFETY AND EFFICACY OF CABERGOLINE ON PREGNANCY OUTCOME IN PATIENTS WITH MICROPROLACTINOMA
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 25
Abstract
BACKGROUND Cabergoline (CAB) has emerged as an effective and well-tolerated drug for the treatment of hyperprolactinemia. However, the drug was included in the pregnancy risk category B by US Food and drug administration. There is limited literature evidence on the use of CAB for treating microprolactinoma during pregnancy, especially among Indian population. The present study was conducted to evaluate the pregnancy outcomes in patients with microprolactinoma, who underwent CAB treatment. MATERIALS AND METHODS The prospective study was conducted in a clinical practice setting in India from Jan 2016 to Dec 2017. The study included female subjects with microprolactinoma, aged between 20-35 years, treated with CAB (0.5 mg to 1.5 mg per week) for a period of 4-12 months, prior to conception and during early weeks of gestation. Level of prolactin was measured at diagnosis, pregnancy confirmation and at the 3rd month of gestation. Pregnancy, delivery and neonatal complications were the outcome measures considered. Statistical analysis involved descriptive analysis of the study variables. RESULTS The study included a total of 16 subjects with an average age of 26±3.15 years. The average level of prolactin decreased from 122.5±32 mcg/ltr. at diagnosis to 32 (28-54) mcg/ltr. at conception. Spontaneous abortion, pre-term delivery, and neonatal complications were observed in 37.5% (n=6) of the cases. CONCLUSION The current study findings corroborate the previous literature evidence suggesting CAB as an effective drug for the treatment of prolactinomas, specifically microprolactinoma. The study demonstrates that CAB administration, prior to conception and during early weeks of gestation, is not significantly associated with pregnancy-related complications.
Authors and Affiliations
Pattanaik S. R
Keywords
Related Articles
- EP ID EP567046
- DOI 10.18410/jebmh/2018/392
- Views 111
- Downloads 0
ATYPICAL FABRY’S DISEASE
Fabry‟s disease (angiokeratoma corporis diffusa) is an X linked recessive lysosomal storage disorder caused by the deficiency of alpha galactosidase A (alpha gal A) which causes progressive accumulation of glycosphingoli...
TUBERCULOSIS OF THE PAROTID GLAND – HOW WE DIAGNOSE & MANAGE IT?
BACKGROUND The Parotid gland is the most common salivary gland to be affected by different pathological variants of swellings which present as a mass in the retromandibular area. The pathology of these lesions varies fro...
ROLE OF PALLIATIVE RADIOTHERAPY AND BEST SUPPORTIVE CARE IN LOCALLY ADVANCED CARCINOMA LUNG
BACKGROUND Lung cancer is presently the leading cause of cancer death and most of the patients present in advanced stage where symptom palliation is the main aim. However, there is no well-defined recommendation regardin...
PREVALENCE OF SUBSTANCE ABUSE AMONG ADOLESCENTS AND YOUNG ADULTS IN RURAL BANGALORE- AN EPIDEMIOLOGICAL STUDY
BACKGROUND According to world drug report, youth from urban settings have been topping the charts for drug abuse. The alarming rate of drug abuse and especially the increase of drug abuse among youngsters has had detrime...
FOREIGN BODY GRANULOMA OF CONJUNCTIVA AFTER THORN INJURY: A CASE REPORT
As foreign body wounds of the eye are very common, many ocular injuries are caused by thorns, fragments of wood or husks of grains, which are retained in eye initiating granulomatous reaction, very commonly seen in rural...